Am J Transplant, Volume 19, Suppl 3 Archives - Page 101 of 214 - ATC Abstracts

2019 American Transplant Congress
CNV Screening For End-stage Renal Disease
C. E. Fishman, B. Chang, A. Shaked, B. J. Keating
Surgery, University of Pennsylvania, Philadelphia, PA
*Purpose: The prevalence of ESRD in the United States was 2,160.7 cases per one million individuals in 2016, and a primary cause of ESRD was…
2019 American Transplant Congress
Paradoxical Differential Post-transplant Rates Of Change Of Serum Proteins In Pediatric Liver Patients With Evidence For A Novel Sarcopenic-dependent Serum Protein Stimulating Factor
C. M. Schmidt¹, J. Molleston², G. S. Rao², C. A. Kubal¹, S. Atoa¹, R. S. Mangus¹
¹Surgery, Transplant Division, Indiana University, Indianapolis, IN, ²Pediatrics, Division of GI and Hepatology, Indiana University, Indianapolis, IN
*Purpose: Pediatric patients with liver disease suffer from hypoalbuminemia, sarcopenia, and malnutrition. This study aims to quantify differential rates of change (ROC) and post-TX normalization…
2019 American Transplant Congress
Prognostic Value Of Dobutamine Stress Echocardiography In Heart Transplantation Recipients
A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha
Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: Dobutamine stress echocardiography (DSE) carries a class IIa recommendation in the ISHLT guidelines for screening of cardiac allograft vasculopathy (CAV). Positive DSEs have a…
2019 American Transplant Congress
Idarucizumab For The Reversal Of Dabigatran In Patients Undergoing Heart Transplantation
J. Van Keer¹, T. Vanassche¹, W. Droogne¹, S. Rex², F. Rega³, J. Van Cleemput¹, P. Verhamme¹, M. Naesens⁴
¹Cardiology, University Hospitals Leuven, Leuven, Belgium, ²Anesthesiology, University Hospitals Leuven, Leuven, Belgium, ³Cardiovascular Surgery, University Hospitals Leuven, Leuven, Belgium, ⁴Nephrology, University Hospitals Leuven, Leuven, Belgium
*Purpose: Atrial fibrillation is common among patients with advanced heart failure who are listed for transplantation. Idarucizumab is a monoclonal antibody fragment that was developed…
2019 American Transplant Congress
Extracorporeal Photopheresis for Specific Immune Tolerance Responses in Heart Transplant Recipients
M. J. Barten¹, K. Klaeske², J. Wittke², M. Borger², J. Garbade², S. Lehmann³, H. Reichenspurner¹, M. Dieterlen²
¹Cardiovascular Surgery, University Heart Center, Hamburg, Germany, ²Cardiac Surgery, University Heart Center Leipzig, Leipzig, Germany, ³Cardiacr Surgery, University Heart Center Leipzig, Leipzig, Germany
*Purpose: Extracorporeal photopheresis (ECP) treatment following heart transplantation (HTx) may induce transplant tolerance. A monitoring tool for successful ECP treatment would allow determination of patient-specific…
2019 American Transplant Congress
Outcomes after Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States
M. Bowring, K. Jackson, H. Wasik, A. Neu, J. Garonzik-Wang, C. Durand, N. Desai, A. Massie, D. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: Kidneys from donors at increased infectious risk for disease transmission (IRDs) confer substantial survival benefit in adults, yet the impact of IRDs in pediatric…
2019 American Transplant Congress
The Predictive Value Of Pre-transplant Biopsies For Short-term And Long-term Graft Function In Kidney Transplantation
H. Zhang¹, L. Liu¹, S. Yang², W. Chen², X. Chen¹, Y. Li², C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: The predictive capacity of previous pre-transplant histologic scoring systems for short-term and long-term graft function in kidney transplantation has not been adequately validated.*Methods: Deceased…
2019 American Transplant Congress
Delayed Graft Function as a Survival Prognostic Factor in Elderly Recipients of Kidney Transplantation
G. J. Piñeiro, E. Guillen, P. Ventura, J. V. Torregrosa, R. Gelpi, I. Revuelta, F. Cofan, E. De Sousa, D. Cucchiari, J. Ugalde, F. Oppenheimer, F. Diekmann, N. Esforzado
Nephrology and Kidney Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain
*Purpose: Kidney transplantation (KT) provides advantages in terms of survival compared with dialysis. However, in elderly recipients, despite a better long-term survival, a high mortality…
2019 American Transplant Congress
“Desens Light”: Single Center Experience Using Rituximab for High Immunologic Risk Kidney Transplant Recipients with Historic DSA
A. Casillas-Abundis, A. Tambur, A. Shetty, C. D'Agostino, J. R. Leventhal
Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL
*Purpose: To evaluate the effectiveness of rituximab as induction therapy for pts undergoing kidney transplant (Tx) with historic DSA (hDSA) [Desens. Light].*Methods: 104 consecutive pts…
2019 American Transplant Congress
Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States
S. M. Riad¹, A. Tamas¹, S. Jackson², C. Martin¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction regimens for kidney transplant (KT) in heart recipients vary widely among transplant centers. We sought to examine the impact of kidney induction type…